PharmAthene, Inc - PIP

PharmAthene, Inc. is a biodefense company engaged in the development and commercialization of medical countermeasures against biological and chemical threats. As of December 31, 2011, the Company’s biodefense portfolio of product candidates included SparVax, a second generation recombinant protective antigen (rPA) anthrax vaccine; Valortim, a fully human monoclonal antibody for the prevention and treatment of anthrax infection, and rBChE (recombinant butyrylcholinesterase) bioscavanger, a medical countermeasure for nerve agent poisoning by organophosphorous compounds, including nerve gases and pesticides.